169 related articles for article (PubMed ID: 35048397)
1. Review article: epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis.
Scott J; Jones AM; Piper Hanley K; Athwal VS
Aliment Pharmacol Ther; 2022 Feb; 55(4):389-400. PubMed ID: 35048397
[TBL] [Abstract][Full Text] [Related]
2. Current Treatment Options for Cystic Fibrosis-Related Liver Disease.
Staufer K
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202578
[TBL] [Abstract][Full Text] [Related]
3. The natural history of cystic fibrosis liver disease a prospective cohort study.
Rowland M; Drummond J; Connolly L; Daly E; McCormick PA; Bourke B; ;
J Cyst Fibros; 2023 Nov; 22(6):1054-1061. PubMed ID: 37495468
[TBL] [Abstract][Full Text] [Related]
4. Clinical and genetic risk factors for cystic fibrosis-related liver disease in Egyptian CF children: A single-center experience.
El-Faramawy A; Nasr SZ; Emam MMSA; Fahmy HMH
Pediatr Pulmonol; 2024 Feb; 59(2):465-471. PubMed ID: 38038166
[TBL] [Abstract][Full Text] [Related]
5. Emerging clinical perspectives in cystic fibrosis liver disease.
Athwal VS; Scott JA; Fitzpatrick E; Rowland M
Curr Opin Pulm Med; 2021 Nov; 27(6):593-599. PubMed ID: 34482340
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and characteristics of cystic fibrosis liver disease: a study highlighting the lack of histological diagnosis.
Issa Z; Gohy S; Zech F; Baldin P; Delire B; Dahlqvist G
Clin Res Hepatol Gastroenterol; 2022 Nov; 46(9):101977. PubMed ID: 35772685
[TBL] [Abstract][Full Text] [Related]
7. Cystic fibrosis related liver disease and endocrine considerations.
Sherwood JS; Ullal J; Kutney K; Hughan KS
J Clin Transl Endocrinol; 2022 Mar; 27():100283. PubMed ID: 35024343
[TBL] [Abstract][Full Text] [Related]
8. Cystic Fibrosis Liver Disease: Outcomes and Risk Factors in a Large Cohort of French Patients.
Boëlle PY; Debray D; Guillot L; Clement A; Corvol H;
Hepatology; 2019 Apr; 69(4):1648-1656. PubMed ID: 30058245
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of patients with cystic fibrosis undergoing lung transplantation with and without cystic fibrosis-associated liver cirrhosis.
Nash EF; Volling C; Gutierrez CA; Tullis E; Coonar A; McRae K; Keshavjee S; Singer LG; Durie PR; Chaparro C
Clin Transplant; 2012; 26(1):34-41. PubMed ID: 21272072
[TBL] [Abstract][Full Text] [Related]
10. Cystic fibrosis-related liver disease is an independent risk factor for mortality and increased health care resource utilization in hospitalized pediatric patients with cystic fibrosis.
Thavamani A; Umapathi KK; Kutney K; Sferra TJ; Sankararaman S
Pediatr Pulmonol; 2022 Jul; 57(7):1717-1725. PubMed ID: 35499220
[TBL] [Abstract][Full Text] [Related]
11. Hepatic Manifestations of Cystic Fibrosis.
Sakiani S; Kleiner DE; Heller T; Koh C
Clin Liver Dis; 2019 May; 23(2):263-277. PubMed ID: 30947876
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis-related liver disease: Clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies.
Dana J; Debray D; Beaufrère A; Hillaire S; Fabre M; Reinhold C; Baumert TF; Berteloot L; Vilgrain V
J Hepatol; 2022 Feb; 76(2):420-434. PubMed ID: 34678405
[TBL] [Abstract][Full Text] [Related]
13. Cystic Fibrosis Liver Disease: Know More.
Al Sinani S; Al-Mulaabed S; Al Naamani K; Sultan R
Oman Med J; 2019 Nov; 34(6):482-489. PubMed ID: 31745411
[TBL] [Abstract][Full Text] [Related]
14. Cystic fibrosis-associated liver disease in children.
Wasuwanich P; Karnsakul W
Minerva Pediatr; 2020 Oct; 72(5):440-447. PubMed ID: 32418413
[TBL] [Abstract][Full Text] [Related]
15. The emerging burden of liver disease in cystic fibrosis patients: A UK nationwide study.
Toledano MB; Mukherjee SK; Howell J; Westaby D; Khan SA; Bilton D; Simmonds NJ
PLoS One; 2019; 14(4):e0212779. PubMed ID: 30947265
[TBL] [Abstract][Full Text] [Related]
16. Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease.
Rath T; Hage L; Kügler M; Menendez Menendez K; Zachoval R; Naehrlich L; Schulz R; Roderfeld M; Roeb E
PLoS One; 2013; 8(3):e58955. PubMed ID: 23516586
[TBL] [Abstract][Full Text] [Related]
17. Prominent role of gut dysbiosis in the pathogenesis of cystic fibrosis-related liver disease in mice.
Bertolini A; Nguyen M; Zehra SA; Taleb SA; Bauer-Pisani T; Palm N; Strazzabosco M; Fiorotto R
J Hepatol; 2024 Mar; ():. PubMed ID: 38554847
[TBL] [Abstract][Full Text] [Related]
18. Adult-onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity.
Koh C; Sakiani S; Surana P; Zhao X; Eccleston J; Kleiner DE; Herion D; Liang TJ; Hoofnagle JH; Chernick M; Heller T
Hepatology; 2017 Aug; 66(2):591-601. PubMed ID: 28422310
[TBL] [Abstract][Full Text] [Related]
19. Cystic Fibrosis-related Liver Disease is Associated With Increased Disease Burden and Endocrine Comorbidities.
Singh H; Coffey MJ; Ooi CY
J Pediatr Gastroenterol Nutr; 2020 Jun; 70(6):796-800. PubMed ID: 32443033
[TBL] [Abstract][Full Text] [Related]
20. Liver disease in patients with cystic fibrosis.
Kamal N; Surana P; Koh C
Curr Opin Gastroenterol; 2018 May; 34(3):146-151. PubMed ID: 29438119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
